Bank Of New York Mellon Corp Galera Therapeutics, Inc. Transaction History

Bank Of New York Mellon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$8.35 - $12.39 $16,449 - $24,408	-1,970 Reduced 5.75%	32,303 $284,000
Q4 2020 Feb 09, 2021	BUY	$8.02 - $12.81 $81,338 - $129,919	10,142 Added 42.03%	34,273 $350,000
Q2 2020 Aug 12, 2020	BUY	$7.14 - $14.41 $89,499 - $180,629	12,535 Added 108.1%	24,131 $172,000
Q1 2020 May 06, 2020	BUY	$5.89 - $17.67 $68,300 - $204,901	11,596 New	11,596 $110,000

909K

Ticker GRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,821,600
Market Cap $1.07M
Description
Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.